Category: Moms

Fasting and hormonal regulation

Fasting and hormonal regulation

Intermittent fasting Body composition analysis a hodmonal lifestyle choice due regilation its potential benefits for weight loss, body composition, improved insulin sensitivitydisease prevention, and well-being. A study on men who fasted during Ramadan found fasting decreased their sexual desire and frequency of sexual activity, but studies on women are sparse. Endocrinology ; —

During fasting, hepatocytes produce glucose in response to hormonal signals. Glucagon and glucocorticoids are principal regilation hormones that Immunity-boosting superfood supplement in regulating glucose production via gluconeogenesis. However, how these hormone signals are integrated Performance testing for big data applications interpreted to hoormonal biological output is unknown.

Here, we use wnd profiling of gene expression, enhancer dynamics and transcription hromonal TF normonal in Energize your mind and body mouse hormoonal to uncover the regulwtion of cooperation between glucagon and glucocorticoids.

We Faxting that compared to a Lean muscle endurance treatment with Recharge for All Networks hormone, a dual treatment directs hepatocytes to Fasting and hormonal regulation pro-gluconeogenic gene program ans Fasting and hormonal regulation inducing hormona genes.

Glucagon does not only activate single enhancers but hormobal activates enhancer clusters, thereby assisting the loading hirmonal GR regulatioh across Faeting units within the cluster.

In summary, we show that cells integrate extracellular signals Mental agility booster an enhancer-specific mechanism: one Faating TF activates enhancers, thereby Role of fats in metabolism the loading of a Retulation stimulated by a second hormone, leading to synergistic Anti-cancer lifestyle choices induction and a tailored transcriptional response Fastung fasting.

During fasting, glucagon and glucocorticoids regulate gene expression. We found that the glucagon-CREB axis activates enhancers, thereby retulation GR loading onto these enhancers, leading to synergistic regulagion of rwgulation genes. During fasting, significant hormonal and metabolic changes occur to ensure sufficient energy supply anr cells.

Insulin levels decrease while glucagon and glucocorticoids levels increase 1—8. Lipolysis Fasting and hormonal regulation Fwsting tissue leads to release of free fatty acids regu,ation the Best fat burners 9 and protein breakdown Iron properties and characteristics muscle generates amino acids that are also taken up by the liver In turn, the liver is responsible for producing Immunity-boosting superfood supplement in the form of rgeulation and ketone bodies to supply extrahepatic tissues.

Hepatocytes produce glucose by glycogen breakdown and by gluconeogenesis - the de novo synthesis of glucose from non-carbohydrate precursors mainly amino hhormonal coming from hoemonal. Due to hepatic glucose production, circulating glucose levels are only mildly reduced during fasting 4 hormonl, 8regulatiln In addition, hepatocytes oxidize gegulation fatty acids to acetyl CoA, serving Fastinh a precursor for ketone Carbohydrate sensitivity symptoms production Free regulafion acids also play Fasing role in augmenting Fastkng glucose production capacity of the Benefits of protein for athletes Gluconeogenesis is potently stimulated by the two fasting Energy metabolism and immune function glucagon and glucocorticoids.

Reguulation effects of these hormones on andd are widespread and are in part mediated Weight and body composition analysis transcriptional Homeopathic lice treatment Glucagon, a refulation hormone secreted from alpha cells in pancreatic islets, binds the hormoal receptor on hepatocytes and stimulates signal transduction cascades mediated by cAMP hormonao calcium.

These cascades Immunity-boosting superfood supplement various rehulation effects in hepatocytes including enzyme activity regulation, metabolite uptake rgulation transcriptional Fasting and hormonal regulation 15 Fastjng major transcription regulatoon TF activated reguoation glucagon is Kidney bean burgers responsive element binding protein - Regukation Faeting glucagon regjlation, CREB regulates rfgulation genes 18 as reulation as genes responsible for providing gluconeogenic precursors In addition to glucagon, glucocorticoids are also secreted during fasting and dramatically affect hepatic regulatuon expression and Faating.

Glucocorticoids bind the glucocorticoid receptor GRa TF that regulates various hepatic genes, including gluconeogenic genes Martial arts hydration strategies While other TFs were homonal to play a role in regulating gluconeogenic hormmonal expression 1423 hormona, CREB horonal GR were among a group of four TFs that were found to play a genome-wide role in the transcriptional response to fasting and hkrmonal shown to preferentially bind Fassting of hepatic enhancers promoting the fasting response 3.

Among these four TFs, only CREB and GR are potently stimulated regulatiom fasting Fastng. Therefore, CREB and GR hornonal central hhormonal in the regklation response due to their dynamic activation regukation fasting, jormonal widespread binding within fasting enhancers abd their effect on gene expression during fasting.

Early studies have shown that co-infusion of glucagon anf glucocorticoids leads to above-additive glucose production 2425suggesting cooperation between these two hormones. Indeed, studies have shown that the two hormones cooperate in a synergistic manner to induce several genes related to gluconeogenesis 26— We found that following glucocorticoid stimulation, GR binds enhancers, activates them and facilitates the subsequent binding of CREB to the same enhancers.

This is mediated by increase in chromatin accessibility and enhancer activity markers 3. Assisted loading was described by us and others in several scenarios to lead to synergistic gene induction 331 Indeed, enhancer-centered TF cooperativity is emerging as a principal mode of gene regulation [for examples, see 33—39 ].

As detailed above, the cooperation between glucagon and glucocorticoids is well known. However, there are many open questions which we set out to answer in this study: What is the genome-wide transcriptional effect of glucagon and glucocorticoids on hepatocytes? Do the two hormones cooperate to regulate only a handful of genes or is it a cooperation module broadly affecting the transcriptional response to fasting?

Is the crosstalk between the two hormones only cooperative or also antagonistic? What are the determinants of CREB-GR cooperation in terms of enhancer environment, enhancer selectivity, motif strength and TF binding? Glucagon nM Ray biotech, catcorticosterone 1 μM Sigma-Aldrich, cat Isolation and plating of primary mouse hepatocytes PMH was performed as detailed in our published protocol with no modifications Three hours after plating, media was changed to Williams E media ThermoFisher Scientific, cat All hormone treatments were performed 18 h after plating in Williams E media except for adenovirus infection experiments, detailed below.

All animal procedures are compatible with the standards for care and use of laboratory animals. The research has been approved by the Hebrew University of Jerusalem Institutional Animal Care and Use Committee IACUC. The Hebrew University of Jerusalem is accredited by the NIH and by AAALAC to perform experiments on laboratory animals NIH approval number: OPRR-A Total RNA was isolated from primary mouse hepatocytes using NucleoSpin kit Macherey-Nagel cat For qPCR, 1 μg of total RNA was reverse transcribed to generate cDNA Quantabio cat — qPCR was performed using a C Touch thermal cycler CFX96 instrument Bio-Rad using SYBR Green Quantabio cat — Gene values were normalized with a house keeping gene Rpl the aFsting region span exon-intron junctions as a proxy for transcription and in order to avoid confounding post-transcriptional events.

The sequences of primers used in this study are:. PMH were treated with hormone combinations for 1 h. Crosslinked samples were washed in phosphate buffered saline PBS regulafion, resuspended in ChIP lysis buffer 0.

Samples were diluted with ChIP dilution buffer mM NaCl, 17mM Tris-HCl pH8, 1. Antibodies 4 μl per 2 mL sample against H3K27ac Active Motif, cator GR Cell Signaling Technologies, cat were conjugated to magnetic beads Sera-Mag, Merck, cat GE for 2 h at 4°C.

Chromatin was immunoprecipitated with antibody-bead conjugates for 16 h at 4°C. Immunocomplexes were washed sequentially with the following buffers: low-salt buffer 0. Chromatin was de-proteinized with proteinase K Hy Labs, cat EPR for 2 h at 55°C and de-crosslinked for 12 h at 65°C.

DNA was subsequently phenol-chloroform purified and ethanol precipitated. For quality control of RNA yield and library synthesis products, the RNA ScreenTape and D ScreenTape kits both from Agilent TechnologiesQubit RNA HS Assay kit, and Qubit DNA HS Assay kit both from Invitrogen were used for each specific step.

mRNA libraries were prepared from 1 μg RNA using the KAPA Stranded mRNA-Seq Kit, with mRNA Capture Beads KAPA biosystems, cat KK ChIP DNA libraries were prepared using the KAPA HyperPrep Kit KAPA biosystems, cat KR The multiplex sample pool 1.

To separate nuclear and cytoplasmic fractions, we followed the REAP protocol 41 with modifications - while the cells were still adhered to the plate, plasma membrane was disrupted using 0. Cells were scraped, collected to a tube and incubated on ice for 10 min.

Samples were centrifuged 4°C, rpm, 3 min. and supernatant the cytoplasmic fraction were transferred to a new tube. Supernatant is the nuclei fraction. For whole cell Fzsting, RIPA was added directly on adherent cells followed by scraping and centrifugation 4°C, rpm, 10 min.

Membranes were incubated with secondary peroxidase AffiniPure goat anti-rabbit immunoglobulin GJackson Laboratory, cat — or anti-mouseJackson Laboratory; cat — for 1 h, followed by washes and a 1-minute incubation with western blotting detection reagent Cytiva Amersham ECL prime, cat RPN Imaging and quantification were done with ChemiDoc Bio-Rad.

After 24 h, hormones were added for downstream experiments. Ad-DN-CREB was kindly provided by Charles Vinson National Cancer Institute, USA.

Fastq files were mapped to the mm10 mouse genome assembly using Bowtie2 42 with default parameters. Tag directories were made using the makeTagDirectory option in HOMER H3K27ac GR and CREB peaks were called using MACS2 narrowPeak option All site overlaps were performed by the MergePeaks option in HOMER.

Distance between sites was measured by the annotatePeaks option in HOMER gegulation option. Selected gene loci were visualized by the integrated genome browser IGV Differential gene expression was evaluated by DEseq2 46 via the HOMER platform under default parameters.

As part of our definition of synergistic induction, we calculated the sum of increased gene expression of the two single treatments by adding the RPKM values of the two single treatments. We compared the sum of single treatments to the RPKM value of the dual treatment for full details of synergistic definition, see Results section.

The normalized tag counts of each gene were used for the analysis. Peak-calling was performed by MACS2, sites common to at least two replicates were merged and ENCODE blacklisted sites were omitted.

De novo motif enrichment analysis was performed using the findMotifsGenome option in HOMER parameter -size given. The entire enhancer landscape all H3K27ac sites across all conditions was used as background to account for possible sequence bias.

When the analysis was repeated with automatically-generated background which matches GC content the rank of GRE and CRE did not change.

Peak-calling was performed by MACS2, sites from both replicates were merged and ENCODE blacklisted sites were omitted. Differential binding was determined by DEseq2 via the HOMER package default parameters, except norm2total option which was applied as is needed in TF ChIP-seq.

Unassisted Fastign were defined as corticosterone-increased GRBS that are not further increased in the dual treatment. Tag distribution around peak center or transcription start site aggregate plots were analyzed using the annotatePeaks option in HOMER parameters: -size -hist Tag density box plots was analyzed using the annotatePeaks option in HOMER.

In all cases the plotted data is an average of all replicates. Enhancer regultaion were analyzed in the vicinity of 91 assisted sites and reguation randomly-selected unassisted sites. Dnase hypersensitive sites that are found in fasted mice 319 and are located Motif searches and H3K27ac quantification within enhancer clusters included only hypersensitive regions and not intermediate inaccessible regions between enhancer units.

The occurrence of GREs and CREs was found using the annottatePeaks option in HOMER parameter: -size given. HOMER motifs used: cre.

: Fasting and hormonal regulation

Key Hormones Involved in Metabolism

Apr 20, Updated Nov 17, Learn more about SCL Health's Nutrition and Weight Loss and Bariatrics services. This is especially true when it comes to health and fitness trends, like Intermittent Fasting.

Research shows that this popular diet can have powerful effects on the brain and body. Intermittent Fasting is an eating pattern that alternates between periods of eating and fasting. So, the longer you go between meals, the more your body exhausts its insulin supply. This is when you start burning fat.

It is recommended that the starting time be earlier in the day to optimize metabolism and avoid eating at the end of the day or late at night, which is linked to increased fat storage and inefficient use of food.

Like most things in life, there are pros and cons. For one, adjusting to the fasting stage of the program might come along with side effects like fatigue, dehydration, heartburn, or anemia. No one knows you like you know you.

We analyzed CREB ChIP-seq from PMH treated with glucagon for 1 h as well as three different genome-wide outputs RNA-seq, DNase-seq and GR ChIP-seq from mice. Food was removed at the beginning of the inactive phase, when lights went on in the animal facility i.

zeitgeber time 0, ZT0. This was done to prevent the reported disruption of circadian clock when mice encounter fasting in the beginning of the active phase Livers from both the fasted and fed groups were collected at the same time ZT0.

All data is available in Gene Expression Omnibus GEO under accession number GSE Lists of fasting-induced genes and fasting-activated Dnase hypersensitive sites were previously generated and are openly available These lists were generated as follows: differential gene expression or Dnase accessibility were evaluated by DEseq2 46 via the HOMER platform under default parameters.

CCCTC-binding factor CTCF ChIP-seq sites in mouse livers were downloaded from GSE CTCF binding in livers from ad libitum fed mice collected at ZT22 and ZT10 was analyzed, combined and visualized on IGV. All conditions in all of the described experiments were performed in three biological replicates except for GR ChIP-seq which was performed in two biological replicates.

Error bars represent standard deviation of biological replicates. In pairwise comparisons, statistical significance was determined by a two-tailed, unpaired t test. In multiple comparisons, statistical significance was determined by ordinary one-way ANOVA comparisons were made between all conditions, only statistically significant comparisons are depicted in most cases.

We aimed to find what is the nature and extent of glucagon and glucocorticoids crosstalk in regulating hepatic gene expression. We treated primary mouse hepatocytes PMH with glucagon and corticosterone the major glucocorticoid found in mice , either alone or in a dual treatment for 3 h and analyzed their transcriptome using RNA-seq Figure 1A.

The 3 h time point was selected in order to capture mostly primary transcriptional effects rather than secondary ones.

After determining differential gene expression as compared to the non-treated control, we found overt gene regulation by a single treatment of either glucagon or corticosterone. This was evident in the numbers of induced and repressed genes Figure 1B , Supplementary Table S1.

These findings show that glucagon and corticosterone have a prominent, rapid and widespread effect on hepatic gene expression. When comparing the two sets of genes regulated by each single hormone treatment, we found a significant overlap. This shows that although the two hormones initiate utterly different signaling pathways and activate different TFs, the transcriptional programs imposed by them resembles each other considerably Figure 1C.

Transcriptomic profiling reveals intricate crosstalk between glucagon and corticosterone. Scheme of experimental setup. Primary mouse hepatocytes were treated with either glucagon nM , corticosterone 1 μM or both in a dual treatment for 3 h.

Then, RNA was extracted and sequenced via RNA-seq. The overlap in the identity of induced and repressed genes between the different treatments is shown, revealing substantial overlap in the transcriptional programs of glucagon and corticosterone. Also, a considerable number of genes is only regulated in the dual treatment.

nt — non-treated; gluc — glucagon; cort — corticosterone. While the pairwise comparisons above are useful in assessing the extent of gene regulation, it is less suitable for uncovering potential crosstalk between the two hormones. To discern the dominant crosstalk patterns between glucagon and corticosterone, we performed k -means clustering on all genes induced in at least one treatment Figure 1D.

The resulting clusters revealed two major crosstalk modes between glucagon and corticosterone. Clusters 1 and 2 show antagonism between the two hormones whereby one hormone led to gene induction that was dampened by the second hormone in the dual treatment.

Conversely, in clusters 3, 4 and 5 the two hormones augmented each other's effect, leading to stronger gene induction in the dual treatment compared to the single treatments.

This pattern was most prominent in cluster 5 where an apparent synergistic effect is seen in which the dual treatment leads to markedly higher induction compared to either glucagon or corticosterone treatments alone.

This is in line with the finding that many genes were only induced in the dual treatment and not in the single treatments Figure 1C. While antagonistic and synergistic expression patterns are evident from the k -means clustering analysis, we wanted to more robustly define antagonism and synergism using fixed parameters and statistical tests.

Antagonism between glucagon and corticosterone was defined as a gene induced by the single treatment compared to both the non-treated control and the dual treatment. For example, a glucagon-induced gene whose induction is dampened in the dual treatment will be determined as antagonistic.

Based on these criteria, we found glucagon-induced genes that are antagonized by corticosterone. Reciprocally, 66 corticosterone-induced genes are antagonized by glucagon Figure 2A , Supplementary Table S1. To find what are the cellular pathways that antagonistic genes participate in, we performed pathway enrichment analysis using GeneAnalytics We found that the glucagon-induced genes which corticosterone antagonizes participate in pathways involving transforming growth factor β signaling and immune-related pathways rather than metabolic pathways.

In contrast, corticosterone-induced genes antagonized by glucagon are related to lipid and bile metabolism Supplementary Table S2. Reciprocal antagonism between fasting hormones coincides with synergistic gene induction.

The relationship between glucagon and corticosterone was defined with clear cutoffs: i A glucagon-induced gene antagonized by corticosterone must meet 2 criteria: induction by glucagon compared to the non-treated control and induction by glucagon compared to the dual treatment.

ii A corticosterone-induced gene antagonized by glucagon must meet 2 criteria: induction by corticosterone compared to the non-treated control and induction by corticosterone compared to the dual treatment. iii A synergistically-induced gene must meet 4 criteria: induction by the dual treatment compared to the non-treated control, compared to glucagon and compared to corticosterone.

Moreover, the gene expression increase in the dual treatment must be higher than the sum of increased gene expression of the two single treatments. An example of a gene from each group is shown. Gene expression was determined by qPCR.

nt — non-treated; gluc — glucagon; cort — corticosterone; RPKM — reads per kilobase per million. The k -means clustering pointed to a prominent synergistic effect of the two hormones.

Synergy is defined as an effect of two conditions that is greater than the sum of both conditions tested individually. To clearly determine synergy in our dataset, we set several complementing criteria, all of which must be met for a gene to be determined as synergistic: the gene is induced in the dual treatment compared to the: a non-treated control, b the glucagon single treatment and c the corticosterone single treatment.

d In addition, for a gene to be defined as synergistic, its increase in expression in the dual treatment must be higher than the sum of increases in the two single treatments combined.

Thus, only genes that pass three pairwise comparisons both statistically and with a fold change cutoff and show a fold change in the dual treatment that is higher than the sum of the two single treatments were defined as synergistic.

Strikingly, even under these strict criteria, genes were found to be synergistically induced by glucagon and corticosterone, showing that synergy is a central crosstalk mode for these two hormones Figure 2A , Supplementary Table S1. In summary, these results show that the crosstalk between glucagon and corticosterone leads to a complex gene induction pattern that could be divided to 3 main patterns: i Genes induced by one hormone with no effect by the second hormone.

ii Genes induced by one hormone with this induction dampened by the second hormone in a dual treatment. iii Genes synergistically induced by both hormones whereby the induction in the dual treatment is greater than the sum of the effect of both single treatments.

A representative gene from each group is shown in Figure 2B profiled via quantitative PCR, qPCR. To explore which group of genes resembles the transcriptional program at play in the liver during fasting in vivo, we compared all gene groups to genes induced in mouse liver following 24 h of fasting [previously published by us, 3 ].

These results suggest that the majority of antagonistic genes are not part of the hepatic fasting response while the synergistic group of genes more closely resembles the gene grogram induced during fasting.

To get insights into the biological processes regulated by synergistically-induced genes, we performed pathway enrichment analysis. The synergistic group of genes was highly enriched in pathways related to gluconeogenesis and catabolic routes leading to gluconeogenesis i.

amino acid metabolism and urea cycle; Supplementary Table S2. This finding is in accordance with our previous studies showing that a dual treatment of glucagon and corticosterone leads to a synergistic increase in gluconeogenesis from both pyruvate and amino acid precursors 3 , This also aligns with the observed synergistic glucose production following infusion of both hormones to dogs and humans 24 , Thus, the cooperative gluconeogenic effect of glucagon and corticosterone is associated with an extensive synergistic gene induction program of gluconeogenic genes.

The above findings suggest that the pro-gluconeogenic transcriptional response occurring during fasting is dominated by glucagon-corticosterone cooperation. We have previously shown that the transcriptional response to fasting is characterized by widespread changes in enhancer activity displaying altered chromatin accessibility and histone acetylation 3.

Thus, we hypothesized that glucagon-corticosterone cooperation will be reflected in altered enhancer dynamics. To explore this, we profiled enhancer dynamics in response to combinatorial hormone treatment glucagon, corticosterone and a dual treatment in PMH.

Enhancer activity was measured by chromatin immunoprecipitation sequencing ChIP-seq of the well-established active histone mark H3Kacetyl H3K27ac Focusing first on regions adjacent to the promoter, we found that regions neighboring glucagon-induced genes show a glucagon-dependent increase in H3K27ac.

A similar association between gene induction and H3K27ac levels is observed in corticosterone- and dual-induced genes Figure 3A. Thus, promoter-proximal regions show increased enhancer activity in response to hormone treatment.

Antagonistic genes showed increased H3K27ac in the single treatment while in the dual treatment this increase was significantly dampened. In contrast, the promoter-proximal regions of synergistic genes showed enhancer activation in both single treatments, which was potently augmented in the dual treatment Figure 3B.

The above analysis focused on H3K27ac signal proximal to promoters of hormone-induced genes. To more broadly examine hormone-dependent enhancer activity without distance constraints, we first defined H3K27ac sites genome-wide via ChIP-seq peak-calling see Methods. Then, we measured a hormone-dependent increase in H3K27ac signal within all H3K27ac sites genome-wide.

We found notable enhancer dynamics following hormone treatments. Glucagon led to activation of 1, enhancers, corticosterone activated 2, enhancers and the dual treatment led to activation of 5, enhancers Supplementary Table S3.

Together, these results show that the cooperation between fasting hormones leads to major alterations in enhancer status which is concordant with the observed gene expression patterns.

Dynamics in promoter-proximal H3K27ac accompanies gene induction patterns. H3K27ac signal was measured in regions surrounding transcription start sites TSS of hormone-induced genes.

Hormone treatment leads to enhancer activation around hormone-induced genes in a pattern that is concordant with gene induction. H3K27ac signal was measured in regions surrounding TSS of antagonistic and synergistic genes.

Enhancers adjacent to antagonistic genes show increased activity in the single treatment while in the dual treatment their activity is reduced back to basal levels. In contrast, enhancers adjacent to synergistic genes show increased activity in the single treatments, with further augmentation in the dual treatment.

Thus, enhancer activation and gene induction are completely concordant, suggesting gene induction is driven by enhancer activation. To predict which TFs mediate hormone-dependent enhancer activation, we performed de novo motif enrichment analysis on enhancers activated by single and dual treatments.

The most enriched motif within glucagon-activated enhancers was the cAMP response element CRE bound by CREB. The most enriched motif within corticosterone-activated enhancers was the glucocorticoid response element GRE bound by GR.

The two most highly enriched motifs in dual-activated enhancers were the GRE and CRE Supplementary Figure S1.

This is in complete agreement with the TFs known to be activated by glucagon and corticosterone — CREB and GR, respectively. These results attest to the functional relevance of the defined enhancer groups and suggest that the cooperation between glucagon and corticosterone in regulating genes is mediated via CREB and GR.

Due to the prevalence of both TF motifs within hormone-activated enhancer regions, we hypothesized that the synergy between glucagon and corticosterone is mediated by a synergistic cooperation between CREB and GR within enhancers. We postulated that this cooperation is brought about via assisted loading within enhancers see Introduction as this cooperative model was previously shown to promote synergistic gene expression 31 , In a previous report we showed that GR assists CREB binding next to gluconeogenic genes 3.

However, the enhancer environment, the motif determinants and the genome-wide transcriptional outcomes of GR-CREB assisted loading were never explored. Importantly, while CREB binding was shown to be assisted by GR at some sites, the binding pattern of GR and whether it changes between the single and dual treatments is unknown.

Due to the enhancer activation patterns and motif enrichment analyses Figure 3 , Supplementary Table S3 , we hypothesized that CREB-GR assisted loading is bi-lateral.

This is an unexplored notion of TF cooperativity and we tackled it by performing ChIP-seq for GR in all four conditions. As expected, following both corticosterone and the dual treatment, more GR binding sites GRBS were detected Supplementary Table.

S4 and GR binding intensity was markedly increased Figure 4A. Moreover, de novo motif enrichment analysis revealed the GRE as the top enriched motif in GRBS found in the corticosterone and the dual treatments, while the GRE was missing in the non-treated or glucagon-treated conditions Supplementary Table.

These results show that, as expected, noteworthy GR binding to the genome occurs only following corticosterone stimulation and is mediated by binding to GREs. Corticosterone-dependent GR binding is augmented by glucagon. Enhancer activity was measured by H3K27ac signal in regions surrounding GRBS.

The increase in GR binding is associated with enhancer activation in both the corticosterone and dual treatments. GR binding in mouse liver in the fed or fasted conditions was quantified.

Corticosterone- and dual-activated GRBS show increased GR binding in mouse liver following fasting [fasting-dependent GR ChIP-seq data was obtained from 3 ]. Enhancer activity in mouse liver in the fed or fasted conditions was evaluated by chromatin accessibility as measured by levels of Dnase-seq signal.

Corticosterone- and dual-activated GRBS reside within fasting-activated enhancers [fasting-dependent chromatin accessibility data was obtained from 3 ].

To examine a possible promoting effect of glucagon on GR binding, we evaluated dynamic GR binding by determining differential binding following hormone treatment using fold change and p value cutoffs as compared to the non-treated control.

There were no sites showing increased GR binding following glucagon treatment. This suggests that, as expected and as shown further below , glucagon does not directly stimulate GR binding.

In contrast, 1, sites showed increased GR binding following corticosterone treatment, aligning well with known GR biology and with the potent effect corticosterone had on gene expression in PMH Figure 1.

Remarkably, 1, GRBS showed an increase following the dual treatment, of which were not increased in the single corticosterone treatment Figure 4A , B , Supplementary Table S5.

The marked increase in GR binding is associated with a concordant increase in enhancer activity around the GRBS Figure 4C. Importantly, the sites where GR binding was increased in corticosterone- or dual-treated cells also show increased GR binding and enhancer activity in mouse liver following fasting, suggesting these sites are functionally relevant not only in corticosterone-treated PMH but also during fasting in vivo [Figure 4D , E ; fasting-dependent chromatin accessibility and GR ChIP-seq data was obtained from 3 ].

The observation that GRBS are found only in the dual treatment suggests that GR binding is substantially increased in the presence of glucagon, presumably due to assisted loading.

To show this effect from a different angle and to substantiate it statistically, we performed a differential GR binding comparison directly between the corticosterone and the dual treatments.

We found 91 GRBS in which GR binding was significantly increased in the dual treatment compared to corticosterone alone Figure 5A , Supplementary Table S5. Therefore, we have shown in two separate analyses that corticosterone-dependent GR binding is significantly increased in the presence of glucagon.

The difference in the number of glucagon-augmented GRBS between the two different analyses vs. Due to the higher reliability of the direct comparison, we chose to focus on this group of sites where glucagon strongly assists GR binding. In contrast, sites where GR binding is unaffected by glucagon i.

We found that unassisted sited comprise the vast majority of corticosterone-increased sites Therefore, all further analyses of assisted sites are compared to corticosterone-increased GRBS Figure 4.

GR binding is prominently increased by glucagon in an enhancer-specific manner. Example GRBS are shown in genome browser tracks together with H3K27ac, CREB binding, chromatin accessibility as well as CRE and GRE occurrence.

Glucagon treatment alone led to significant enhancer activation around assisted GRBS, while it did not affect unassisted GRBS compare with Figure 4C. Assisted GRBS show increased GR binding in mouse liver following fasting [fasting-dependent GR ChIP-seq data was obtained from 3 ].

Enhancer activity was evaluated by chromatin accessibility as measured by increased Dnase-seq signal in regions surrounding GRBS. Assisted GRBS reside within fasting-activated enhancers [fasting-dependent chromatin accessibility data was obtained from 3 ].

Interestingly, assisted sites do not reach GR binding intensities that are higher than unassisted sites. Rather, only in the presence of glucagon do assisted sites reach comparable levels of unassisted sited Figure 5B , compare to Figure 4B. Thus, in unassisted sites GR is able to optimally bind without help while in assisted sites, maximal GR binding is only achieved with the help of glucagon.

Assisted loading is a TF crosstalk model in which direct protein-protein interaction between the two TFs is not required. Instead, the model is based on one TF activating the enhancer, thereby allowing better access to it by the second TF.

In accordance with the model, we found that H3K27ac is increased in assisted sites following glucagon treatment alone while in unassisted sites glucagon has no effect on enhancer activity Figure 5C , compare to Figure 4C.

This is consistent with a scenario in which a glucagon-activated TF, leads to enhancer activation, permitting subsequent GR binding. In line with the PMH data, GR binding and enhancer activity in assisted sites is increased during fasting in mouse liver [Figure 5D , E ; fasting-dependent GR ChIP-seq and chromatin accessibility data was obtained from 3 ], suggesting the activation of these enhancers is pertinent during fasting in vivo.

Of note, enhancers harboring assisted sites are more accessible than enhancers harboring unassisted sites Figure 5E , compare to Figure 4E.

Taken together, these findings show that glucagon alone activates enhancers harboring assisted GRBS and potentiates GR binding there. Also, while GR can optimally bind unassisted sites following corticosterone, only following a dual treatment does GR optimally bind assisted sites at a level comparable to unassisted sites.

To eliminate secondary effects, all ChIP-seq experiments in this study where done after only 1 h of treatment. Thus, it is unlikely that the stimulatory effect of glucagon on GR depends on secondary effects of glucagon target genes.

Rather, a crosstalk between glucagon and corticosterone downstream signaling is the probable cause. The effect of glucagon on GR binding is enhancer-specific i.

occurs only in assisted sites and not on unassisted sites. Nonetheless, to exclude a global effect of glucagon signaling on GR activity, we examined GR mRNA and protein levels as well as GR nuclear localization. We found that the mRNA or protein levels of GR or CREB where not increased in the dual treatment compared to single treatments Supplementary Figure S2A, B.

Also, glucagon did not augment corticosterone-dependent GR nuclear localization Supplementary Figure S2C. Therefore, the effect of glucagon on GR is restricted to assisted sites rather than generally affecting GR activity.

In support of this, de novo motif enrichment analysis revealed that in unassisted sites, GRE was the top enriched motif while CRE was absent.

In stark contrast, the two most enriched motifs within assisted sites were CRE and GRE Supplementary Figure S3 , associating CREB in assisted loading of GR. In accordance, the binding of CREB following glucagon treatment was very prominent near assisted sites while it was nearly undetected in unassisted sites [Figures 5A , 6A ; CREB ChIP-seq data was obtained from 3 ].

In addition, CREB binding sites were significantly closer to assisted GRBS as compared to unassisted sites Figure 6B. This further implicates CREB in glucagon-mediated assisted loading. To show that the glucagon-CREB axis is responsible for synergistic gene expression, we infected cells with an adenovirus expressing a dominant negative peptide against CREB [DN-CREB, 51 ].

As expected, DN-CREB negated glucagon-dependent induction of a CREB target gene Fh1 while it did not affect the corticosterone-dependent induction of a known GR target gene Mt1. In contrast, we found that DN-CREB abolished synergistic gene induction altogether Ppp1r3g and Gpcpd1 ; Figure 6C.

Importantly, we measured GR binding by ChIP and found that binding of GR at an unassisted site was unaltered by DN-CREB while GR occupancy at assisted sites was abolished by DN-CREB Figure 6D.

CREB assists the loading of GR following glucagon treatment. Quantifying differential binding of CREB near GRBS shows preferential CREB binding near assisted sites. Measuring the distance between GRBS and CREB binding sites shows that CREB tends to bind closer to assisted sites.

Primary mouse hepatocytes were infected with adenovirus expressing either DN-CREB Ad-DN-CREB or a control Ad-Ctrl. After 24 h, cells were treated with the indicated hormones for 3 h. Gene expression was measured by qPCR. Ad-DN-CREB abolished glucagon-dependent induction which is unaffected by corticosterone Fh1 as well as synergistic gene induction Ppp1r3g and Gpcpd1.

After 24 h, cells were treated with the indicated hormones for 1 h followed by GR ChIP. GR binding was measured via qPCR. Scanning motif occurrences in assisted and unassisted GRBS shows that the percentage of the CRE increases in assisted sites while GRE occurrences decrease in assisted sites as compared to unassisted sites.

Measuring the distance between CREs and GREs in enhancers harboring assisted GRBS shows no fixed inter-motif distance. To find the percentage of GRBSs that harbor GRE or CRE motifs, we searched for motif occurrence in assisted vs. unassisted sites. Indeed, the occurrence of the CRE more than tripled in assisted sited compared to unassisted sites.

Remarkably, the occurrence of the GRE was reduced in assisted sites Figure 6E. We hypothesized that this reduction is due to assisted sites harboring GREs that are less similar to the consensus GRE, leading to them not being identified in the targeted motif search.

To explore this, we examined the GRE motif score given in the de novo motif enrichment analysis. The closer the motif score is to 1, the closer it is to the consensus motif. We found that the GRE motif score in unassisted sites is 0. This finding supports the concept that in assisted sites, GR binding to weaker motifs is facilitated by CREB which activates the enhancers, making them more amenable to binding, thereby improving the low incidence of GR binding events to a weaker motif.

This interpretation is in line with the observation that assisted sites show weaker GR binding in the corticosterone treatment but in the dual treatment reach binding intensity comparable to unassisted sites Compare Figures 4B to 5B.

The assisted loading model assumes one TF in this case CREB facilitates the binding of another TF in this case GR by enhancer activation and irrespective of direct TF-TF interaction.

According to this assumption and in contrast to TF-TF heterodimerization, the motifs for both TFs could be placed tens or even hundreds of nucleotides apart. To explore this, we isolated assisted sited where both a GRE and a CRE were found and binned them by the distance between the two motifs.

We found no preference to a fixed number of nucleotides spacing the two motifs [as is the case in heterodimerization 52 ]. Rather, motif distance spanned between 10 and nucleotides, with a roughly even distribution at nucleotides and upwards Figure 6F.

Taken together, these findings reveal that glucagon leads to enhancer activation by CREB binding, which assists GR binding. In the lack of a glucagon signal and enhancer activation, GR binding is abolished or significantly diminished due to inaccessibility to the enhancer harboring a weaker GRE.

Enhancer units within a cluster often cooperate in regulating a single gene The enhancer cluster phenomenon is convincingly explained by the finding that enhancer clusters are physically proximal in the three-dimensional space, thereby assembling one regulatory apparatus that promotes gene transcription.

Thus, the concept of enhancer activation can be expanded to enhancer cluster activation. By proxy, assisted loading can occur within an enhancer cluster whereby one TF binds one enhancer unit within the cluster, leading to activation of the enhancer cluster at large. Then, the other TF more easily binds a second enhancer unit within the same cluster.

To examine this hypothesis, we scanned assisted sites for nearby enhancers, using chromatin accessibility data as an acceptable marker for enhancers Based on previous conventions 57 , we scanned a Most of the remaining sites resided in clusters containing multiple enhancers, up to 11 enhancers within a cluster Figure 7A.

Unassisted sites also tended to reside within clusters but in contrast to assisted sites, these clusters contained less enhancer units Figure 7A. To check if glucagon is able to increase the activity of enhancer clusters at large and not only individual enhancer units harboring assisted sites , we evaluated enhancer activity of all enhancer units within the clusters.

A single treatment of glucagon led to robust activation of enhancer units within enhancer clusters Figure 7B. Notably, this activation was evident also after exclusion of enhancer units harboring assisted sites Figure 7C.

In accordance, we found that CREB binding following glucagon treatment is increased in enhancer units across clusters harboring assisted sites when compared to clusters harboring unassisted sites Figure 7D. Importantly, CREB binding was also increased even when excluding enhancer units harboring assisted sites Figure 7E.

Thus, glucagon-dependent enhancer activation and CREB binding are observed across enhancer units of clusters where assisted loading is found and not only in the individual enhancer unit harboring the assisted site. Enhancer clusters often reside near synergistically-induced genes. Examples are shown in Figure 7F and Supplementary Figure S4 where the loci of five synergistic genes are depicted, showing glucagon-dependent CREB binding in the cluster, glucagon-dependent enhancer activation across the cluster and assisted GR binding.

This occurs in sites with co-occurrence of CREs and GREs and is associated with fasting-dependent increase in enhancer activity. Moreover, only the edges of enhancer clusters are flanked by CTCF while there is no CTCF binding within a cluster.

This further suggests that the units within enhancer clusters function together to regulate gene expression and are proximally-located in three-dimensional space, positioned within the same chromatin loop Figure 7F , Supplementary Figure S4.

In summary, glucagon leads to CREB binding and enhancer activation across the cluster. In the dual treatment this potentiates GR binding, leading to synergistic gene induction. Assisted loading of GR occurs within enhancer clusters, driving synergistic gene expression.

Quantification of enhancer units within enhancer clusters shows that assisted sites reside within enhancer clusters containing a higher number of enhancer units compared to unassisted sites. Enhancer activity was measured by H3K27ac signal in enhancer units within enhancer clusters. Glucagon treatment alone led to significant enhancer activation within enhancer units around assisted GRBS.

The effect of glucagon was evident even after excluding the enhancer unit harboring assisted GRBS, showing that the effect of glucagon spans across the cluster and not only in the specific enhancer unit.

CREB binding was measured in enhancer units within enhancer clusters. Glucagon treatment alone led to significant CREB binding within enhancer units around assisted GRBS. The effect of glucagon is evident even after excluding the enhancer unit harboring assisted GRBS, showing that the effect of glucagon spans across the cluster and not only in the specific enhancer unit.

Genome browser tracks of synergistically-induced genes shows enhancer clusters broadly activated by glucagon. These clusters harbor CREs, GREs, CREB binding, assisted GR binding as well as fasting-activated enhancers. Enhancer clusters are flanked by CTCF.

Cells are routinely exposed to a myriad of extracellular signals and are constantly responding to them, thereby adapting to a changing environment and maintaining homeostasis.

The manner by which extracellular signals are integrated and translated in cells to produce a coherent response is poorly understood.

Here, we investigated the hepatic fasting response which is heavily reliant on transcriptional regulation 14 , 23 , This response is controlled by the combinatorial effect of several signals, chief among them are glucagon and glucocorticoids.

We treated PMH with different combinations of hormones and analyzed the transcriptional response to these treatments as well as the dynamics in enhancer activation imposed by them. We found that the crosstalk between glucagon and glucocorticoids is not monotonic.

Rather, the two hormones cooperate to synergistically induce some genes while antagonize each other's response in different sets of genes. Synergy and antagonism are accompanied with corresponding enhancer activity in the gene loci.

Thus, the crosstalk between the two hormones is gene-specific and enhancer-specific and is not uniform across the genome. The complex crosstalk between the two hormones could be a mechanism for a tailored response: glucocorticoids increase not only during fasting but following various kinds of stress Thus, combinations of glucocorticoids with other signals could together produce a response more specific to the particular stress.

Indeed, we found that antagonized genes have roles unrelated to the fasting response. In contrast, synergistically-induced genes play key roles in the fasting response in various functions supporting gluconeogenesis.

These findings suggest that in contrast to single treatments, integration of extracellular signals leads to a tailored response addressing the specific gene programs needed to maintain homeostasis.

Synergy between GR and the cAMP-PKA pathway in regulating gene expression was shown 3 , 19 , 26—29 , 60 , However, the mechanism behind it is unclear.

Several reports show that the cAMP-PKA pathway augment GR in diverse manners: cAMP was shown to induce transcription of the GR gene 62 , 63 and increase its mRNA stability 64 , PKA was shown to phosphorylate GR 66 , 67 and a physical interaction between GR and CREB was reported 26 , 62 the glucagon-cAMP-PKA pathway was shown to induce the gene levels of two GR co-activators — PGC1α 27 , 68 and CRTC2 Taken on face value, these types of crosstalk seem to provide a possible explanation to the augmenting effect of glucagon on GR-dependent gene expression which we have observed.

However, we assert that these effects cannot reconcile our observation for several reasons: a We observe no glucagon-dependent GR gene induction, increase in GR protein levels or increase in GR nuclear localization. b The effect of glucagon on GR was highly enhancer-specific.

Most GRBS were unaffected by glucagon altogether. This shows that the augmenting effect of glucagon is brought about only at particular enhancers and an effect of glucagon on overall GR activity as previously described could not explain this observation. c Inhibiting CREB does not affect GR target genes but do abolish synergistic gene induction.

d CREB inhibition does not affect GR binding at unassisted sites but does impair it at assisted sites. e We observed both a synergistic and an antagonistic crosstalk between glucagon and corticosterone simultaneously.

This bifurcated response could not be explained by an overall effect of glucagon on GR. f We did not find a fixed motif distance between CREs and GREs, making the physical interaction scenario between GR and CREB less likely in our case. We found that the glucagon-CREB axis leads to enhancer activation that assists GR binding near synergistically-induced genes.

We have previously shown the reciprocal phenomenon whereby GR assists the loading of CREB in a different set of enhancers 3. We provide evidence that the assisting TF i. the TF binding the enhancer first and activating it is the factor whose motif has higher affinity its corresponding TF.

The assisted TF is the factor with a weaker motif, therefore it can only reach optimal binding following enhancer activation and increased accessibility. Therefore, in a bi-lateral assisted loading model, two TFs maximize a biological response by coordinating optimal binding that is only achieved in the presence of the two signals.

The assisted loading mode of cooperation between TFs is particularly fitted for tailoring a transcriptional response to two or more signals because it is gene-specific and enhancer-specific.

Thus, while other modes of cooperation affect all genes regulated by a certain TF, assisted loading leads to synergistic gene induction only on a subset of genes.

It appears that GR serve as an extreme example for assisted loading-type of crosstalk with other TFs. GR binding to the genome was shown to be altered by several TFs under different conditions.

Reciprocally, GR was found to assist the binding of TFs such as FoxA 73 , 74 and CREB 3. Presumably, this high degree of cooperation with various TFs stems from the fact that GR is expressed in virtually all cell types and is activated by glucocorticoids which are secreted following a myriad of stress situations.

Therefore, in order to respond to different types of stress in different cell types and under different circumstances, the glucocorticoid stress signal is integrated with more specific signals via GR assisted loading. Fitting with this scenario, GR binding was found to be increased by STAT5 in livers of mice under a high fat diet, presumably due to increased growth hormone signaling in these mice Thus, it is plausible to assume that GR assisted loading is not restricted to gluconeogenesis but also plays a role in other biological programs.

Our data suggest that assisted loading is not restricted to two TFs binding at the same enhancer. Rather, assisted loading occurs across enhancer units within enhancer clusters. Clusters of enhancers have emerged as a central mode of gene regulation in which several enhancer units share enhancer characteristics chromatin accessibility, histone modifications and together regulate gene expression.

Enhancer units within the cluster are in close proximity in three-dimensional space and thus constitute a regulatory apparatus promoting transcription.

Recent observations suggest that TF binding is controlled by activation of enhancer clusters rather than single enhancers Moreover, it was recently shown that the binding of a TF at one enhancer unit leads to increased binding of the same TF at other units Here, we show that one TF augments the binding of a different TF activated by a different hormone.

Thus, two different hormonal signals are integrated by two different TFs via assisted loading: glucagon activates CREB and increases enhancer activity of the cluster at large, thereby assisting binding of GR stimulated by corticosterone.

Based on these results, it is plausible that glucagon, via CREB, generates an environment conducive to GR binding by increased enhancer cluster acetylation. Cluster-wide histone acetylation was shown to positively affect gene induction via several possible mechanisms Our results point to a scenario whereby the glucagon-CREB axis activates enhancer clusters, assists GR loading to them, eventually leading to synergistic gene expression.

In summary, in this study we provide evidence that by employing assisted loading, two signals are integrated to boost a biological response by coordinating enhancer activation, TF binding and synergistic gene expression. This phenomenon is bi-lateral and is dictated by motif strength, serving to optimize gene regulation by enhancers.

This integration of signals expands beyond single enhancers and is also at play in enhancer clusters. Supplementary Data are available at NAR Online. We would like to thank Dr. Abed Nasereddin and Dr.

Idit Shiff from The Genomic Applications Lab, Hebrew University of Jerusalem, for their invaluable help, support and expertise in high throughput sequencing. Champy M. Mouse functional genomics requires standardization of mouse handling and housing conditions. Google Scholar. Kinouchi K. et al.

Fasting imparts a switch to alternative daily pathways in liver and muscle. Cell Rep. Goldstein I. Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response.

Genome Res. Perry R. Leptin mediates a glucose-fatty acid cycle to maintain glucose homeostasis in starvation. Andersen B. Plasma FGF21 displays a circadian rhythm during a h fast in healthy female volunteers. Unger R.

The effects of total starvation upon the levels of circulating glucagon and insulin in man. Steinhauser M. The circulating metabolome of human starvation. JCI Insight. Carper D. Reappraisal of the optimal fasting time for insulin tolerance tests in mice. Mol Metab.

Grabner G. Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab. Cahill G. Jr Fuel metabolism in starvation. Geisler C. Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice.

Fukao T. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot. Fatty Acids.

Intermittent Fasting For Women Over 40 | BeBalanced Centers

Indeed, several studies have confirmed this finding. Bergendahl et al reported that five-day fasting can increase cortisol levels and shift peak production of cortisol from the morning to the afternoon.

Likewise, J ohnstone et al showed that fasting for 6 days dramatically elevates blood cortisol levels from baseline levels. Similar findings have also been shown for the remainder of stress hormones. In addition to cortisol, epinephrine adrenaline , and norepinephrine are also elevated during Intermittent Fasting.

Indeed, Michalsen reported increased blood levels of both stress hormones during the first 7 days of intermittent fasting schedule. Leptin is a hormone produced by fat tissue that helps your body maintain a healthy weight over time.

This is accomplished by creating a feeling of satiety feeling full to regulate appetite. In addition to suppressing appetite, the hormone also elevates caloric expenditure , and hence helps burn fat.

Similar to insulin, our body can develop resistance to this hormone as well. In leptin resistance , leptin levels become very high.

This causes target cells located in a region of the brain called the hypothalamus, to become desensitized to the hormone. Without the satiety effects of leptin, our body is tricked into constantly feeling hungry which makes it want to eat and store more fat.

Such resistance can develop from:. Fortunately, intermittent fasting can decrease levels of leptin and re-sensitise hypothalamic cells to the hormone. Several studies have provided evidence for the same. In fact, a recent meta-analysis of people , the majority of whom were overweight or obese, discovered that intermittent fasting schedules are related with lower body mass index BMI , leptin blood levels , improved leptin sensitivity and decrease in appetite.

As a heads up, the menstrual cycle describes the series of events that occur in your body each month as it prepares for the possibility of pregnancy each month. On average, it lasts for 28 days, from the first day of your monthly period till the first day of your next monthly period.

During the cycle, your body experiences many hormonal fluctuations, especially in the reproductive hormones estrogen, progesterone, FSH and LH. While intermittent fasting is overall a a healthy dieting strategy, it may exert unwanted side effects on your menstrual cycle.

This is because the female reproductive system is particularly sensitive to calorie consumption and levels. During fasting periods , you limit your caloric intake for a prolonged time period. This can lead to lower progesterone levels, the female hormone that peaks during the second half of the menstrual cycle.

The hormone plays a very important role in ovulation, a critical step involving the release of the egg for fertilization by sperm. By decreasing progesterone levels, intermittent fasting can reduce chances of ovulation , and hence contribute to menstrual irregularities. By restricting calorie consumption during fasting windows, you also expose your body to high levels of stress , as evident by the increase in stress hormones that comes hand in hand with intermittent fasting.

With heightened stress, release of FSH and LH from the pituitary gland , a structure in the brain, is decreased. These are also critically involved in the menstrual cycle, as they regulate release of progesterone and estrogen during the menstrual cycle.

If the fasting window is extended too far , it can trigger menstrual irregularities including amenorrhoea , which is a temporary, intermittent or permanent absence of periods.

Hence, while intermittent fasting schedules are useful in weight loss, they have side effects which extend to your menstrual cycle.

Women , especially those who are beginners to fasting, should regularly consult their health care provider to best optimize meal plans and intermittent fasting strategies. Conclusively, intermittent fasting is all about when you eat, rather than what you eat. It involves restricting eating to certain time frames, and fasting in between.

While it has become extremely popular as a weight loss strategy , its effects on hormones are complex, and depend on the health status of the individual. As an example, intermittent fasting may be particularly beneficial for those predisposed to diabetes , or who have diabetes , as it lowers insulin and burns fat.

A similar landscape exists for obese individuals , where intermittent fasting lowers leptin levels and increases sensitivity to the hormone for satiety. For individuals with hyperthyroidism , intermittent fasting is once again beneficial , as it lowers thyroid hormones to baseline levels.

However, intermittent fasting has also got a fair set of repercussions. Fasting for a prolonged time frame is a major stressor, and elevates stress hormone levels which are bad for the body. For individuals with hypothyroidism , intermittent fasting may exacerbate already low levels of thyroid hormones, and hence worsen symptoms.

Finally, for women on their menstrual cycle, intermittent fasting can mess up their schedule, if not implemented appropriately. Overall, intermittent fasting is a double-edged sword with both benefits and side effects. It is in your best interest to consult a healthcare provider before unpacking the quest of this famous nutritional trend!

Hormone University was created as an educational platform with the mission to improve hormone health through accessible knowledge and to advocate for social impact in our communities.

Coping with pain, infertility, anxiety, depression, body image issues, and, on top of this, judgment is the heavy load most of these women have to bear each day and an important problem we need to tackle as a society.

Receive updates on educational content and relevant news to help you navigate your hormonal health wellness. One of the easiest ways that you can help to rebalance your hormones is by looking at your lifestyle and.

Wild yam — scientifically known as Dioscorea villosa — is a plant that is native to North America and widely. SHOP Hormonal Wellness. Seal of Approval. Understanding the Effects of the Diet on Hormones. Should I try Intermittent Fasting? Written by: Hormone University.

Verified by: Hormone University. Table of Contents Toggle What is Intermittent Fasting? How does Intermittent Fasting affect hormone levels? What are the range of hormones it targets? Intermittent Fasting and Insulin Levels Can Intermittent Fasting improve insulin resistance and hormonal balance?

Intermittent Fasting and Cortisol levels What impact does Intermittent Fasting have on cortisol and stress hormones? Intermittent Fasting and Leptin levels How does intermittent fasting affect leptin levels and appetite control?

Intermittent Fasting and the Menstrual Cycle Can intermittent fasting help regulate menstrual cycles, and hormonal imbalances? What is Intermittent Fasting? Intermittent Fasting and Insulin Levels. Can Intermittent Fasting improve insulin resistance and hormonal balance? Intermittent Fasting and Cortisol levels.

What impact does Intermittent Fasting have on cortisol and stress hormones? Intermittent Fasting and Leptin levels. How does intermittent fasting affect leptin levels and appetite control? Such resistance can develop from: too little sleep too much stress too much of the wrong foods.

Intermittent Fasting and the Menstrual Cycle. The marked increase in GR binding is associated with a concordant increase in enhancer activity around the GRBS Figure 4C. Importantly, the sites where GR binding was increased in corticosterone- or dual-treated cells also show increased GR binding and enhancer activity in mouse liver following fasting, suggesting these sites are functionally relevant not only in corticosterone-treated PMH but also during fasting in vivo [Figure 4D , E ; fasting-dependent chromatin accessibility and GR ChIP-seq data was obtained from 3 ].

The observation that GRBS are found only in the dual treatment suggests that GR binding is substantially increased in the presence of glucagon, presumably due to assisted loading. To show this effect from a different angle and to substantiate it statistically, we performed a differential GR binding comparison directly between the corticosterone and the dual treatments.

We found 91 GRBS in which GR binding was significantly increased in the dual treatment compared to corticosterone alone Figure 5A , Supplementary Table S5. Therefore, we have shown in two separate analyses that corticosterone-dependent GR binding is significantly increased in the presence of glucagon.

The difference in the number of glucagon-augmented GRBS between the two different analyses vs. Due to the higher reliability of the direct comparison, we chose to focus on this group of sites where glucagon strongly assists GR binding.

In contrast, sites where GR binding is unaffected by glucagon i. We found that unassisted sited comprise the vast majority of corticosterone-increased sites Therefore, all further analyses of assisted sites are compared to corticosterone-increased GRBS Figure 4.

GR binding is prominently increased by glucagon in an enhancer-specific manner. Example GRBS are shown in genome browser tracks together with H3K27ac, CREB binding, chromatin accessibility as well as CRE and GRE occurrence.

Glucagon treatment alone led to significant enhancer activation around assisted GRBS, while it did not affect unassisted GRBS compare with Figure 4C. Assisted GRBS show increased GR binding in mouse liver following fasting [fasting-dependent GR ChIP-seq data was obtained from 3 ].

Enhancer activity was evaluated by chromatin accessibility as measured by increased Dnase-seq signal in regions surrounding GRBS. Assisted GRBS reside within fasting-activated enhancers [fasting-dependent chromatin accessibility data was obtained from 3 ].

Interestingly, assisted sites do not reach GR binding intensities that are higher than unassisted sites. Rather, only in the presence of glucagon do assisted sites reach comparable levels of unassisted sited Figure 5B , compare to Figure 4B.

Thus, in unassisted sites GR is able to optimally bind without help while in assisted sites, maximal GR binding is only achieved with the help of glucagon.

Assisted loading is a TF crosstalk model in which direct protein-protein interaction between the two TFs is not required. Instead, the model is based on one TF activating the enhancer, thereby allowing better access to it by the second TF. In accordance with the model, we found that H3K27ac is increased in assisted sites following glucagon treatment alone while in unassisted sites glucagon has no effect on enhancer activity Figure 5C , compare to Figure 4C.

This is consistent with a scenario in which a glucagon-activated TF, leads to enhancer activation, permitting subsequent GR binding.

In line with the PMH data, GR binding and enhancer activity in assisted sites is increased during fasting in mouse liver [Figure 5D , E ; fasting-dependent GR ChIP-seq and chromatin accessibility data was obtained from 3 ], suggesting the activation of these enhancers is pertinent during fasting in vivo.

Of note, enhancers harboring assisted sites are more accessible than enhancers harboring unassisted sites Figure 5E , compare to Figure 4E. Taken together, these findings show that glucagon alone activates enhancers harboring assisted GRBS and potentiates GR binding there.

Also, while GR can optimally bind unassisted sites following corticosterone, only following a dual treatment does GR optimally bind assisted sites at a level comparable to unassisted sites.

To eliminate secondary effects, all ChIP-seq experiments in this study where done after only 1 h of treatment. Thus, it is unlikely that the stimulatory effect of glucagon on GR depends on secondary effects of glucagon target genes. Rather, a crosstalk between glucagon and corticosterone downstream signaling is the probable cause.

The effect of glucagon on GR binding is enhancer-specific i. occurs only in assisted sites and not on unassisted sites. Nonetheless, to exclude a global effect of glucagon signaling on GR activity, we examined GR mRNA and protein levels as well as GR nuclear localization.

We found that the mRNA or protein levels of GR or CREB where not increased in the dual treatment compared to single treatments Supplementary Figure S2A, B.

Also, glucagon did not augment corticosterone-dependent GR nuclear localization Supplementary Figure S2C. Therefore, the effect of glucagon on GR is restricted to assisted sites rather than generally affecting GR activity. In support of this, de novo motif enrichment analysis revealed that in unassisted sites, GRE was the top enriched motif while CRE was absent.

In stark contrast, the two most enriched motifs within assisted sites were CRE and GRE Supplementary Figure S3 , associating CREB in assisted loading of GR. In accordance, the binding of CREB following glucagon treatment was very prominent near assisted sites while it was nearly undetected in unassisted sites [Figures 5A , 6A ; CREB ChIP-seq data was obtained from 3 ].

In addition, CREB binding sites were significantly closer to assisted GRBS as compared to unassisted sites Figure 6B. This further implicates CREB in glucagon-mediated assisted loading. To show that the glucagon-CREB axis is responsible for synergistic gene expression, we infected cells with an adenovirus expressing a dominant negative peptide against CREB [DN-CREB, 51 ].

As expected, DN-CREB negated glucagon-dependent induction of a CREB target gene Fh1 while it did not affect the corticosterone-dependent induction of a known GR target gene Mt1. In contrast, we found that DN-CREB abolished synergistic gene induction altogether Ppp1r3g and Gpcpd1 ; Figure 6C.

Importantly, we measured GR binding by ChIP and found that binding of GR at an unassisted site was unaltered by DN-CREB while GR occupancy at assisted sites was abolished by DN-CREB Figure 6D.

CREB assists the loading of GR following glucagon treatment. Quantifying differential binding of CREB near GRBS shows preferential CREB binding near assisted sites. Measuring the distance between GRBS and CREB binding sites shows that CREB tends to bind closer to assisted sites. Primary mouse hepatocytes were infected with adenovirus expressing either DN-CREB Ad-DN-CREB or a control Ad-Ctrl.

After 24 h, cells were treated with the indicated hormones for 3 h. Gene expression was measured by qPCR. Ad-DN-CREB abolished glucagon-dependent induction which is unaffected by corticosterone Fh1 as well as synergistic gene induction Ppp1r3g and Gpcpd1.

After 24 h, cells were treated with the indicated hormones for 1 h followed by GR ChIP. GR binding was measured via qPCR. Scanning motif occurrences in assisted and unassisted GRBS shows that the percentage of the CRE increases in assisted sites while GRE occurrences decrease in assisted sites as compared to unassisted sites.

Measuring the distance between CREs and GREs in enhancers harboring assisted GRBS shows no fixed inter-motif distance. To find the percentage of GRBSs that harbor GRE or CRE motifs, we searched for motif occurrence in assisted vs.

unassisted sites. Indeed, the occurrence of the CRE more than tripled in assisted sited compared to unassisted sites. Remarkably, the occurrence of the GRE was reduced in assisted sites Figure 6E.

We hypothesized that this reduction is due to assisted sites harboring GREs that are less similar to the consensus GRE, leading to them not being identified in the targeted motif search.

To explore this, we examined the GRE motif score given in the de novo motif enrichment analysis. The closer the motif score is to 1, the closer it is to the consensus motif.

We found that the GRE motif score in unassisted sites is 0. This finding supports the concept that in assisted sites, GR binding to weaker motifs is facilitated by CREB which activates the enhancers, making them more amenable to binding, thereby improving the low incidence of GR binding events to a weaker motif.

This interpretation is in line with the observation that assisted sites show weaker GR binding in the corticosterone treatment but in the dual treatment reach binding intensity comparable to unassisted sites Compare Figures 4B to 5B. The assisted loading model assumes one TF in this case CREB facilitates the binding of another TF in this case GR by enhancer activation and irrespective of direct TF-TF interaction.

According to this assumption and in contrast to TF-TF heterodimerization, the motifs for both TFs could be placed tens or even hundreds of nucleotides apart.

To explore this, we isolated assisted sited where both a GRE and a CRE were found and binned them by the distance between the two motifs.

We found no preference to a fixed number of nucleotides spacing the two motifs [as is the case in heterodimerization 52 ].

Rather, motif distance spanned between 10 and nucleotides, with a roughly even distribution at nucleotides and upwards Figure 6F.

Taken together, these findings reveal that glucagon leads to enhancer activation by CREB binding, which assists GR binding.

In the lack of a glucagon signal and enhancer activation, GR binding is abolished or significantly diminished due to inaccessibility to the enhancer harboring a weaker GRE.

Enhancer units within a cluster often cooperate in regulating a single gene The enhancer cluster phenomenon is convincingly explained by the finding that enhancer clusters are physically proximal in the three-dimensional space, thereby assembling one regulatory apparatus that promotes gene transcription.

Thus, the concept of enhancer activation can be expanded to enhancer cluster activation. By proxy, assisted loading can occur within an enhancer cluster whereby one TF binds one enhancer unit within the cluster, leading to activation of the enhancer cluster at large.

Then, the other TF more easily binds a second enhancer unit within the same cluster. To examine this hypothesis, we scanned assisted sites for nearby enhancers, using chromatin accessibility data as an acceptable marker for enhancers Based on previous conventions 57 , we scanned a Most of the remaining sites resided in clusters containing multiple enhancers, up to 11 enhancers within a cluster Figure 7A.

Unassisted sites also tended to reside within clusters but in contrast to assisted sites, these clusters contained less enhancer units Figure 7A. To check if glucagon is able to increase the activity of enhancer clusters at large and not only individual enhancer units harboring assisted sites , we evaluated enhancer activity of all enhancer units within the clusters.

A single treatment of glucagon led to robust activation of enhancer units within enhancer clusters Figure 7B. Notably, this activation was evident also after exclusion of enhancer units harboring assisted sites Figure 7C.

In accordance, we found that CREB binding following glucagon treatment is increased in enhancer units across clusters harboring assisted sites when compared to clusters harboring unassisted sites Figure 7D. Importantly, CREB binding was also increased even when excluding enhancer units harboring assisted sites Figure 7E.

Thus, glucagon-dependent enhancer activation and CREB binding are observed across enhancer units of clusters where assisted loading is found and not only in the individual enhancer unit harboring the assisted site.

Enhancer clusters often reside near synergistically-induced genes. Examples are shown in Figure 7F and Supplementary Figure S4 where the loci of five synergistic genes are depicted, showing glucagon-dependent CREB binding in the cluster, glucagon-dependent enhancer activation across the cluster and assisted GR binding.

This occurs in sites with co-occurrence of CREs and GREs and is associated with fasting-dependent increase in enhancer activity. Moreover, only the edges of enhancer clusters are flanked by CTCF while there is no CTCF binding within a cluster.

This further suggests that the units within enhancer clusters function together to regulate gene expression and are proximally-located in three-dimensional space, positioned within the same chromatin loop Figure 7F , Supplementary Figure S4. In summary, glucagon leads to CREB binding and enhancer activation across the cluster.

In the dual treatment this potentiates GR binding, leading to synergistic gene induction. Assisted loading of GR occurs within enhancer clusters, driving synergistic gene expression.

Quantification of enhancer units within enhancer clusters shows that assisted sites reside within enhancer clusters containing a higher number of enhancer units compared to unassisted sites.

Enhancer activity was measured by H3K27ac signal in enhancer units within enhancer clusters. Glucagon treatment alone led to significant enhancer activation within enhancer units around assisted GRBS.

The effect of glucagon was evident even after excluding the enhancer unit harboring assisted GRBS, showing that the effect of glucagon spans across the cluster and not only in the specific enhancer unit.

CREB binding was measured in enhancer units within enhancer clusters. Glucagon treatment alone led to significant CREB binding within enhancer units around assisted GRBS. The effect of glucagon is evident even after excluding the enhancer unit harboring assisted GRBS, showing that the effect of glucagon spans across the cluster and not only in the specific enhancer unit.

Genome browser tracks of synergistically-induced genes shows enhancer clusters broadly activated by glucagon. These clusters harbor CREs, GREs, CREB binding, assisted GR binding as well as fasting-activated enhancers.

Enhancer clusters are flanked by CTCF. Cells are routinely exposed to a myriad of extracellular signals and are constantly responding to them, thereby adapting to a changing environment and maintaining homeostasis. The manner by which extracellular signals are integrated and translated in cells to produce a coherent response is poorly understood.

Here, we investigated the hepatic fasting response which is heavily reliant on transcriptional regulation 14 , 23 , This response is controlled by the combinatorial effect of several signals, chief among them are glucagon and glucocorticoids.

We treated PMH with different combinations of hormones and analyzed the transcriptional response to these treatments as well as the dynamics in enhancer activation imposed by them.

We found that the crosstalk between glucagon and glucocorticoids is not monotonic. Rather, the two hormones cooperate to synergistically induce some genes while antagonize each other's response in different sets of genes. Synergy and antagonism are accompanied with corresponding enhancer activity in the gene loci.

Thus, the crosstalk between the two hormones is gene-specific and enhancer-specific and is not uniform across the genome. The complex crosstalk between the two hormones could be a mechanism for a tailored response: glucocorticoids increase not only during fasting but following various kinds of stress Thus, combinations of glucocorticoids with other signals could together produce a response more specific to the particular stress.

Indeed, we found that antagonized genes have roles unrelated to the fasting response. In contrast, synergistically-induced genes play key roles in the fasting response in various functions supporting gluconeogenesis.

These findings suggest that in contrast to single treatments, integration of extracellular signals leads to a tailored response addressing the specific gene programs needed to maintain homeostasis.

Synergy between GR and the cAMP-PKA pathway in regulating gene expression was shown 3 , 19 , 26—29 , 60 , However, the mechanism behind it is unclear.

Several reports show that the cAMP-PKA pathway augment GR in diverse manners: cAMP was shown to induce transcription of the GR gene 62 , 63 and increase its mRNA stability 64 , PKA was shown to phosphorylate GR 66 , 67 and a physical interaction between GR and CREB was reported 26 , 62 the glucagon-cAMP-PKA pathway was shown to induce the gene levels of two GR co-activators — PGC1α 27 , 68 and CRTC2 Taken on face value, these types of crosstalk seem to provide a possible explanation to the augmenting effect of glucagon on GR-dependent gene expression which we have observed.

However, we assert that these effects cannot reconcile our observation for several reasons: a We observe no glucagon-dependent GR gene induction, increase in GR protein levels or increase in GR nuclear localization. b The effect of glucagon on GR was highly enhancer-specific.

Most GRBS were unaffected by glucagon altogether. This shows that the augmenting effect of glucagon is brought about only at particular enhancers and an effect of glucagon on overall GR activity as previously described could not explain this observation.

c Inhibiting CREB does not affect GR target genes but do abolish synergistic gene induction. d CREB inhibition does not affect GR binding at unassisted sites but does impair it at assisted sites.

e We observed both a synergistic and an antagonistic crosstalk between glucagon and corticosterone simultaneously.

This bifurcated response could not be explained by an overall effect of glucagon on GR. f We did not find a fixed motif distance between CREs and GREs, making the physical interaction scenario between GR and CREB less likely in our case.

We found that the glucagon-CREB axis leads to enhancer activation that assists GR binding near synergistically-induced genes. We have previously shown the reciprocal phenomenon whereby GR assists the loading of CREB in a different set of enhancers 3.

We provide evidence that the assisting TF i. the TF binding the enhancer first and activating it is the factor whose motif has higher affinity its corresponding TF. The assisted TF is the factor with a weaker motif, therefore it can only reach optimal binding following enhancer activation and increased accessibility.

Therefore, in a bi-lateral assisted loading model, two TFs maximize a biological response by coordinating optimal binding that is only achieved in the presence of the two signals. The assisted loading mode of cooperation between TFs is particularly fitted for tailoring a transcriptional response to two or more signals because it is gene-specific and enhancer-specific.

Thus, while other modes of cooperation affect all genes regulated by a certain TF, assisted loading leads to synergistic gene induction only on a subset of genes. It appears that GR serve as an extreme example for assisted loading-type of crosstalk with other TFs.

GR binding to the genome was shown to be altered by several TFs under different conditions. Reciprocally, GR was found to assist the binding of TFs such as FoxA 73 , 74 and CREB 3.

Presumably, this high degree of cooperation with various TFs stems from the fact that GR is expressed in virtually all cell types and is activated by glucocorticoids which are secreted following a myriad of stress situations.

Therefore, in order to respond to different types of stress in different cell types and under different circumstances, the glucocorticoid stress signal is integrated with more specific signals via GR assisted loading.

Fitting with this scenario, GR binding was found to be increased by STAT5 in livers of mice under a high fat diet, presumably due to increased growth hormone signaling in these mice Thus, it is plausible to assume that GR assisted loading is not restricted to gluconeogenesis but also plays a role in other biological programs.

Our data suggest that assisted loading is not restricted to two TFs binding at the same enhancer. Rather, assisted loading occurs across enhancer units within enhancer clusters.

Clusters of enhancers have emerged as a central mode of gene regulation in which several enhancer units share enhancer characteristics chromatin accessibility, histone modifications and together regulate gene expression. Enhancer units within the cluster are in close proximity in three-dimensional space and thus constitute a regulatory apparatus promoting transcription.

Recent observations suggest that TF binding is controlled by activation of enhancer clusters rather than single enhancers Moreover, it was recently shown that the binding of a TF at one enhancer unit leads to increased binding of the same TF at other units Here, we show that one TF augments the binding of a different TF activated by a different hormone.

Thus, two different hormonal signals are integrated by two different TFs via assisted loading: glucagon activates CREB and increases enhancer activity of the cluster at large, thereby assisting binding of GR stimulated by corticosterone.

Based on these results, it is plausible that glucagon, via CREB, generates an environment conducive to GR binding by increased enhancer cluster acetylation. Cluster-wide histone acetylation was shown to positively affect gene induction via several possible mechanisms Our results point to a scenario whereby the glucagon-CREB axis activates enhancer clusters, assists GR loading to them, eventually leading to synergistic gene expression.

In summary, in this study we provide evidence that by employing assisted loading, two signals are integrated to boost a biological response by coordinating enhancer activation, TF binding and synergistic gene expression.

This phenomenon is bi-lateral and is dictated by motif strength, serving to optimize gene regulation by enhancers.

This integration of signals expands beyond single enhancers and is also at play in enhancer clusters. Supplementary Data are available at NAR Online. We would like to thank Dr. Abed Nasereddin and Dr. Idit Shiff from The Genomic Applications Lab, Hebrew University of Jerusalem, for their invaluable help, support and expertise in high throughput sequencing.

Champy M. Mouse functional genomics requires standardization of mouse handling and housing conditions. Google Scholar. Kinouchi K. et al. Fasting imparts a switch to alternative daily pathways in liver and muscle. Cell Rep. Goldstein I. Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response.

Genome Res. Perry R. Leptin mediates a glucose-fatty acid cycle to maintain glucose homeostasis in starvation. Andersen B. Plasma FGF21 displays a circadian rhythm during a h fast in healthy female volunteers. Unger R. The effects of total starvation upon the levels of circulating glucagon and insulin in man.

Steinhauser M. The circulating metabolome of human starvation. JCI Insight. Carper D. Reappraisal of the optimal fasting time for insulin tolerance tests in mice.

Mol Metab. Grabner G. Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab. Cahill G. Jr Fuel metabolism in starvation. Geisler C. Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice.

Fukao T. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot.

Fatty Acids. Roden M. The integrative biology of type 2 diabetes. Transcriptional and chromatin regulation during fasting - The Genomic era. Trends Endocrinol. Campbell J. Islet α cells and glucagon—critical regulators of energy homeostasis. Habegger K. The metabolic actions of glucagon revisited.

The three ds of transcription activation by glucagon: direct, delayed, and dynamic. Altarejos J. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Cell Biol. Korenfeld N. Fasting hormones synergistically induce amino acid catabolism genes to promote gluconeogenesis.

Cell Mol Gastroenterol Hepatol. Greulich F. There goes the neighborhood: assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor.

Ratman D. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Præstholm S. Multifaceted control of GR signaling and its impact on hepatic transcriptional networks and metabolism.

Frontiers in Endocrinology. Bideyan L. Hepatic transcriptional responses to fasting and feeding. Genes Dev. Eigler N. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.

Shamoon H. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans.

Imai E. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. Herzig S. CREB regulates hepatic gluconeogenesis through the coactivator PGC Christoffels V.

Hill M. CRTC2 is a coactivator of GR and couples GR and CREB in the regulation of hepatic gluconeogenesis. Voss T. Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism.

Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading. Madsen M. Stefflova K. Cooperativity and rapid evolution of cobound transcription factors in closely related mammals.

Smith R. Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model. Zeitlinger J. Seven myths of how transcription factors read the cis-regulatory code. Curr Opin Syst Biol.

Dynamic regulation of transcriptional states by chromatin and transcription factors. Rao S. Cooperative binding between distant transcription factors is a hallmark of active enhancers. Sönmezer C. Molecular Co-occupancy identifies transcription factor binding cooperativity in vivo.

Caratti G. REVERBa couples the circadian clock to hepatic glucocorticoid action. Charni-Natan M. Protocol for primary mouse hepatocyte isolation. STAR Protoc. Suzuki K. REAP: a two minute cell fractionation method. BMC Res Notes. Langmead B.

Fast gapped-read alignment with bowtie 2. Heinz S. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and b cell identities. Zhang Y. Model-based analysis of chip-Seq MACS. Genome Biol. Robinson J. Integrative genomics viewer.

Love M. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Kim Y. Rev-erbα dynamically modulates chromatin looping to control circadian gene transcription. Vollmers C. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression.

Ben-Ari Fuchs S. GeneAnalytics: an integrative gene set analysis tool for next generation sequencing, RNAseq and microarray data. Creyghton M.

Histone H3K27ac separates active from poised enhancers and predicts developmental state. Ahn S. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos.

Evans R. Nuclear receptors, RXR, and the big bang. Blobel G. Testing the super-enhancer concept. Misteli T. The self-organizing genome: principles of genome architecture and function. Chen Y. Now open: evolving insights to the roles of lysine acetylation in chromatin organization and function.

Thurman R. The accessible chromatin landscape of the human genome. Khan A. dbSUPER: a database of super-enhancers in mouse and human genome.

Huang S. Differential regulation of the immune system in a brain-liver-fats organ network during short-term fasting. Fink G. In retrospect: eighty years of stress.

Liu J. Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway.

Watanabe M. Forskolin and dexamethasone synergistically induce aromatase CYP19 expression in the human osteoblastic cell line SV-HFO. Govindan M. Recruitment of cAMP-response element-binding protein and histone deacetylase has opposite effects on glucocorticoid receptor gene transcription.

Peñuelas I. cAMP activates transcription of the human glucocorticoid receptor gene promoter. Steroid Biochem. Dong Y. The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. Okret S. Regulation of glucocorticoid receptor expression.

Haske T. Phosphorylation of immunopurified rat liver glucocorticoid receptor by the catalytic subunit of cAMP-dependent protein kinase. Singh V. Phosphorylation of rat liver glucocorticoid receptor. Knutti D. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen.

Grontved L. EMBO J. Quagliarini F. Cistromic reprogramming of the diurnal glucocorticoid hormone response by high-fat diet. Hemmer M.

Fasting-induced hormonal regulation of lysosomal function | Cell Research In contrast, we found that DN-CREB abolished synergistic gene induction altogether Ppp1r3g and Gpcpd1 ; Figure 6C. Nutrient Fact Sheets. Google Scholar. The entire enhancer landscape all H3K27ac sites across all conditions was used as background to account for possible sequence bias. Collectively, these results demonstrate that DREAM's nuclear shuttling is required for FGFinduced TFEB nuclear activity.
New data on how intermittent fasting affects female hormones | UIC today Subscribe to Abdominal weight loss Waiting Room. Insulin Fastlng and hyperinsulinemia Fastibg increased androgen male hormones synthesis and decreased estrogen production 14Fasting and hormonal regulation This network hormonql responsible for controlling how the body reacts to stress and maintaining various physiological processes. Assisted GRBS reside within fasting-activated enhancers [fasting-dependent chromatin accessibility data was obtained from 3 ]. Leptin and insulin directly regulate each other. Your comment will be reviewed and published at the journal's discretion.

Fasting and hormonal regulation -

However, any diet or health trend impacts each person very differently. Regarding intermittent fasting, women may respond quite differently than men. Understanding how fasting affects female hormones is essential in creating an effective intermittent fasting strategy and a significant factor in deciding if fasting suits you as a woman.

Intermittent fasting is the practice of regularly switching between a timed period of eating and a timed period of avoiding eating. While many diets focus on what to eat, intermittent fasting is focused on when you eat. Intermittent fasting can be used with a variety of diets and nutritional approaches.

There are many different types of intermittent fasting, such as:. There are also many other types of intermittent fasting. For example, fasting methods have been used to improve physiological function and insulin sensitivity , promote fat loss, and improve thinking and memory.

Intermittent fasting can impact women's hormones and can either be beneficial or potentially harmful - it's all about the frequency and duration of fasting and understanding that women need to fast in a way that supports their changing hormones.

Fasting can be a valuable part of a woman's health routine, and there's evidence of this value in areas such as cancer risk reduction, chronic pain, healing metabolic syndrome, treating PCOS, and supporting mental health. One area that is being researched more and more is how intermittent fasting can impact PCOS.

Intermittent fasting, particularly time-restricted fasting, has shown favorable effects in several studies related to polycystic ovarian syndrome PCOS. Fasting was shown to decrease levels of androgens, like testosterone, while improving insulin resistance and reducing body fat in women with certain types of PCOS.

In some women, intermittent fasting may be therapeutic for hormone regulation. Fasting may not always be beneficial, though. Many benefits of intermittent fasting are due to how one's body adapts to perceived stress.

Short-term stressors can be good for us, helping us to be able to better adapt to stress in the future. With prolonged stress including fasting , the hypothalamus will "turn down" the production of reproductive hormones that are important for ovulation and a healthy menstrual cycle. So it's possible for fasting to be "too much" of a stressor in some women, stressing them enough to prevent healthy ovulation.

Another study looking at the effects of intermittent fasting on DHEA levels showed that fasting could lead to a decrease in DHEA in pre- and post-menopausal women. DHEA has many roles in the body, one of which is to stimulate egg production in premenopausal women, playing a role in fertility.

If you're noticing changes in your period or losing it altogether while fasting, that's a sign that you may be overdoing it. Studies suggest that thyroid function decreases with prolonged fasting, though the thyroid regains its function once fasting is stopped.

Any long-term period of calorie restriction has the potential to slow thyroid function if it isn't balanced with periods of eating adequate calories. Hypothyroidism in women has been linked to fertility issues and potentially to a decrease in progesterone levels.

For women, it's essential to ensure that intermittent fasting isn't causing a reduction of thyroid hormones, especially if she's trying to get pregnant.

One study showed that certain types of fasting alternate-day fasting negatively impacted the blood sugar response in non-obese women. This suggests that women may benefit from some types of fasting more than others and that women who are a healthy body weight may not experience the same benefits as women who are overweight or obese when it comes to blood sugar regulation.

Estrogen plays a vital role in metabolism, impacting insulin sensitivity, cholesterol metabolism, hunger-satiety signaling, and maintaining nutrient balance. Healthy estrogen levels are essential for a healthy metabolism.

As women go through menopause, they can experience symptoms related to decreasing metabolic health as their estrogen levels decline. Progesterone affects how women metabolize the three primary macronutrients: carbohydrates, fats, and proteins.

Progesterone also can play a role in blood glucose regulation, influencing insulin sensitivity throughout the menstrual cycle. Because estrogen and progesterone are constantly communicating with various other hormone systems i.

Understanding how intermittent fasting affects female hormones can help you better gauge how your body would respond to different fasting methods. Working with a functional medicine practitioner to test and evaluate your hormone levels can ensure a safe approach to intermittent fasting and improving metabolic health.

There are three major hormonal stages in a woman's life - premenopausal, perimenopausal, and postmenopausal. Each stage comes with its own hormonal changes. Women considering intermittent fasting should understand how their hormones may be affected by fasting to make the best decisions on the timing and frequency of a fasting method.

While more inclusive studies need to be done to better understand the impacts of fasting on women, there are a few potential contributing reasons for the difference in response. First, women have different hormone profiles than men, and their hormones are constantly in flux.

While men have a hormone profile that is relatively similar daily, women's hormones - at least until after menopause - shift throughout their cycle.

Their response to fasting differs depending on the day and specific part of their cycle. Second, women may be more sensitive to changes in nutrient balance than men due to a molecule called kisspeptin. Kisspeptin controls an integral part of the reproductive pathway and is sensitive to hormones like insulin and leptin, which help us regulate hunger and satiety signaling.

Women have higher levels of kisspeptin than men, which may influence the effect of fasting. Third, women may respond differently to decreases in specific macronutrients, such as protein or carbohydrates.

If women are not eating adequate protein for their body weight and activity levels, the body will sense that amino acids the building blocks of protein are low. If amino acids are too low, it can negatively impact estrogen binding and a hormone called IGF-1 insulin-like growth factor 1.

Both of these are important for thickening the lining of the uterus during the menstrual cycle; if the lining does not thicken, it can negatively impact fertility. Evaluating female hormones can help you and your practitioner understand what is happening with your hormones so that you can structure the best intermittent fasting plan and assess if fasting is appropriate for you.

Retesting periodically when fasting for long periods can help to see if you need to adjust your intermittent fasting schedule. Fasting glucose measures your blood glucose after an overnight fast. Fasting insulin can be a helpful biomarker to evaluate, especially for women interested in using intermittent fasting methods to help treat insulin resistance.

Using a continuous glucose monitor can help you keep track of your blood glucose levels while fasting and can help you make sure levels don't drop into an unhealthy range.

A comprehensive stool test can help a practitioner understand each patient's unique nutrient needs and any digestive support that may be helpful while trying intermittent fasting.

Repeating a stool test periodically while practicing fasting methods can help evaluate nutrient needs and continue personalizing support as much as possible. Women can use intermittent fasting as part of a healthy lifestyle - they just need to fast differently than men!

Intermittent fasting can be a great health tool for women, though women should understand they need to approach fasting differently than men. As women move through different hormonal phases in life, their fasting approach also needs to change. Aligning a fasting schedule with your menstrual cycle is a good starting point to see if the benefits of fasting can work for you.

The most important thing is to make sure you can listen to your body cues and work alongside a practitioner to ensure you don't experience any adverse effects on your hormones from an intermittent fasting protocol.

Documents Tab. Redesigned Patient Portal. Simplify blood panel ordering with Rupa's Panel Builder. Sign in. Sign in Sign up free. Subscribe for free to keep reading!

If you are already subscribed, enter your email address to log back in. Are you a healthcare practitioner? Yes No. Search All Content During the cycle, your body experiences many hormonal fluctuations, especially in the reproductive hormones estrogen, progesterone, FSH and LH.

While intermittent fasting is overall a a healthy dieting strategy, it may exert unwanted side effects on your menstrual cycle. This is because the female reproductive system is particularly sensitive to calorie consumption and levels.

During fasting periods , you limit your caloric intake for a prolonged time period. This can lead to lower progesterone levels, the female hormone that peaks during the second half of the menstrual cycle.

The hormone plays a very important role in ovulation, a critical step involving the release of the egg for fertilization by sperm. By decreasing progesterone levels, intermittent fasting can reduce chances of ovulation , and hence contribute to menstrual irregularities.

By restricting calorie consumption during fasting windows, you also expose your body to high levels of stress , as evident by the increase in stress hormones that comes hand in hand with intermittent fasting.

With heightened stress, release of FSH and LH from the pituitary gland , a structure in the brain, is decreased. These are also critically involved in the menstrual cycle, as they regulate release of progesterone and estrogen during the menstrual cycle.

If the fasting window is extended too far , it can trigger menstrual irregularities including amenorrhoea , which is a temporary, intermittent or permanent absence of periods. Hence, while intermittent fasting schedules are useful in weight loss, they have side effects which extend to your menstrual cycle.

Women , especially those who are beginners to fasting, should regularly consult their health care provider to best optimize meal plans and intermittent fasting strategies. Conclusively, intermittent fasting is all about when you eat, rather than what you eat.

It involves restricting eating to certain time frames, and fasting in between. While it has become extremely popular as a weight loss strategy , its effects on hormones are complex, and depend on the health status of the individual. As an example, intermittent fasting may be particularly beneficial for those predisposed to diabetes , or who have diabetes , as it lowers insulin and burns fat.

A similar landscape exists for obese individuals , where intermittent fasting lowers leptin levels and increases sensitivity to the hormone for satiety.

For individuals with hyperthyroidism , intermittent fasting is once again beneficial , as it lowers thyroid hormones to baseline levels. However, intermittent fasting has also got a fair set of repercussions. Fasting for a prolonged time frame is a major stressor, and elevates stress hormone levels which are bad for the body.

For individuals with hypothyroidism , intermittent fasting may exacerbate already low levels of thyroid hormones, and hence worsen symptoms.

Finally, for women on their menstrual cycle, intermittent fasting can mess up their schedule, if not implemented appropriately. Overall, intermittent fasting is a double-edged sword with both benefits and side effects.

It is in your best interest to consult a healthcare provider before unpacking the quest of this famous nutritional trend! Hormone University was created as an educational platform with the mission to improve hormone health through accessible knowledge and to advocate for social impact in our communities.

Coping with pain, infertility, anxiety, depression, body image issues, and, on top of this, judgment is the heavy load most of these women have to bear each day and an important problem we need to tackle as a society.

Receive updates on educational content and relevant news to help you navigate your hormonal health wellness.

One of the easiest ways that you can help to rebalance your hormones is by looking at your lifestyle and. Wild yam — scientifically known as Dioscorea villosa — is a plant that is native to North America and widely.

SHOP Hormonal Wellness. Seal of Approval. Understanding the Effects of the Diet on Hormones. Should I try Intermittent Fasting? Written by: Hormone University. Verified by: Hormone University. Table of Contents Toggle What is Intermittent Fasting?

How does Intermittent Fasting affect hormone levels? What are the range of hormones it targets? Intermittent Fasting and Insulin Levels Can Intermittent Fasting improve insulin resistance and hormonal balance? Intermittent Fasting and Cortisol levels What impact does Intermittent Fasting have on cortisol and stress hormones?

Intermittent Fasting and Leptin levels How does intermittent fasting affect leptin levels and appetite control? Intermittent Fasting and the Menstrual Cycle Can intermittent fasting help regulate menstrual cycles, and hormonal imbalances?

What is Intermittent Fasting? Intermittent Fasting and Insulin Levels. Can Intermittent Fasting improve insulin resistance and hormonal balance? Intermittent Fasting and Cortisol levels. What impact does Intermittent Fasting have on cortisol and stress hormones? Intermittent Fasting and Leptin levels.

How does intermittent fasting affect leptin levels and appetite control? Such resistance can develop from: too little sleep too much stress too much of the wrong foods.

Intermittent Fasting and the Menstrual Cycle. Can intermittent fasting help regulate menstrual cycles, and hormonal imbalances? Cho Y, Hong N, Kim KW, Cho SJ, Lee M, Lee YH, et al. The effectiveness of intermittent fasting to reduce body mass index and glucose metabolism: a systematic review and meta-analysis.

J Clin Med. doi: Cleveland Clinic. Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms. Current pain and headache reports , 14 2 , 80— Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men.

Eur J Endocrinol ; Bergendahl M, Vance ML, Iranmanesh A, Thorner MO, Veldhuis JD. Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men.

J Clin Endocrinol Metab ; Professional, C. Effects of intermittent fasting on the circulating levels and circadian rhythms of hormones.

Endocrinology and Metabolism , 36 4 , — Intermittent fasting: What is its impact on hormones? Medical News Today.

SCL Health.

Anr fasting, hepatocytes produce Fasting and hormonal regulation in response to hormonal signals. Glucagon and glucocorticoids are principal fasting hormones that cooperate in Fastkng glucose production regulatino gluconeogenesis. Immunity-boosting superfood supplement, hkrmonal these hormone signals Natural detox recipes integrated and interpreted to a biological output is unknown. Here, we use genome-wide profiling of gene expression, enhancer dynamics and transcription factor TF binding in primary mouse hepatocytes to uncover the mode of cooperation between glucagon and glucocorticoids. We found that compared to a single treatment with each hormone, a dual treatment directs hepatocytes to a pro-gluconeogenic gene program by synergistically inducing gluconeogenic genes.

Author: Malajas

3 thoughts on “Fasting and hormonal regulation

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com